We are subject to income tax requirements in various jurisdictions in the U.S. and internationally. Many of these jurisdictions face
budgetary shortfalls or have unpredictable enforcement activity. Increases in applicable tax rates, implementation of new taxes,
changes in applicable tax laws and interpretations of these tax laws and actions by tax authorities in jurisdictions in which we
operate could reduce our after-tax income and have an adverse effect on our results of operations.
Aspects of our business, including Health Care and personal care, are subject to many laws and governmental regulations, including
regulations by the Food and Drug Administration and comparable foreign agencies, as well as potential litigation. Adverse
regulatory action, including a recall, regulatory or other governmental investigation, or product liability or other litigation may
adversely affect our financial condition and business operations.
Our sales and results of operations may also be adversely impacted by new legal requirements, including healthcare reform
legislation, excise or other taxes, financial reform legislation and regulations, export control and foreign sanctions legislation, and
climate change and other environmental legislation and regulations. The costs and other effects of pending litigation and
administrative actions against us and new legal requirements cannot be determined with certainty. For example, new legislation
or regulations may result in increased costs to us, directly for our compliance or indirectly to the extent suppliers increase prices
of goods and services because of increased compliance costs or reduced availability of raw materials.